E
BioAtla, Inc. BCAB
$0.356 -$0.0002-0.06% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 11.20% 34.00% 44.72% 68.23% 41.06%
Total Depreciation and Amortization -49.78% -23.75% -38.04% -15.56% -21.03%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -32.93% -110.22% -58.98% -37.62% -32.08%
Change in Net Operating Assets 431.21% 91.10% 46.75% 38.26% -111.00%
Cash from Operations 26.43% 47.16% 43.91% 81.23% 20.34%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -80.74% -- 6,150.34% -100.00% 41.04%
Repurchase of Common Stock 73.68% -123.08% 100.00% 74.55% 67.24%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -116.00% -2,938.46% 7,726.05% 65.85% 95.65%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 25.37% 45.91% 74.94% 81.23% 20.95%